Vistagen Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2012 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Vistagen Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2012 to Q3 2024.
  • Vistagen Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 30.6M shares, a 205% increase year-over-year.
  • Vistagen Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 19.4M shares, a 178% increase from 2022.
  • Vistagen Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 6.96M shares, a 5.45% increase from 2021.
  • Vistagen Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 6.6M shares, a 92.3% decline from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 30.6M +20.6M +205% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 30.6M +23.3M +317% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 19.4M +12.2M +170% Jan 1, 2024 Mar 31, 2024 10-K 2024-06-11
Q4 2023 29.4M +22.5M +326% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-13
Q3 2023 10M +3.15M +45.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 7.34M +450K +6.54% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 7.16M +279K +4.06% Jan 1, 2023 Mar 31, 2023 10-K 2023-06-28
Q4 2022 6.89M +150K +2.23% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-13
Q3 2022 6.89M +453K +7.03% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 6.89M +556K +8.78% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 6.88M Jan 1, 2022 Mar 31, 2022 10-K 2023-06-28
Q4 2021 6.74M Oct 1, 2021 Dec 31, 2021 10-K 2023-06-28
Q3 2021 6.44M Jul 1, 2021 Sep 30, 2021 10-K 2023-06-28
Q2 2021 6.33M Apr 1, 2021 Jun 30, 2021 10-K 2023-06-28
Q4 2015 1.77M +463K +35.6% Oct 1, 2015 Dec 31, 2015 10-Q 2016-02-16
Q3 2015 1.62M +345K +27% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-16
Q1 2015 1.47M +368K +33.5% Jan 1, 2015 Mar 31, 2015 10-K 2016-06-24
Q4 2014 1.3M +192K +17.3% Oct 1, 2014 Dec 31, 2014 10-K 2016-06-24
Q3 2014 1.28M +198K +18.3% Jul 1, 2014 Sep 30, 2014 10-K 2016-06-24
Q2 2014 1.23M -19.6M -94.1% Apr 1, 2014 Jun 30, 2014 10-K 2016-06-24
Q1 2014 1.1M Jan 1, 2014 Mar 31, 2014 10-K 2015-06-29
Q4 2013 1.11M -17.2M -93.9% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-17
Q3 2013 1.08M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-19
Q2 2013 20.8M +4M +23.7% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-12
Q4 2012 18.3M Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-14
Q2 2012 16.8M Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.